Dr. Berberian will drive the company’s new product development strategy in regenerative products. He has more than 30 years of experience in senior clinical, education and medical executive roles.
Dr. Berberian is a professor at Hackensack (N.J.) Meridian School of Medicine and authored more than 100 peer-reviewed publications.
